• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,606.55
    134.60 (+0.24%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,716.35(%)
  • Trent
    2,815.00 3,497.35(%)
  • Raymond
    1,024.00 1,024.00(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 530.65(%)
  • One 97
    1,829.50 1,829.50(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,727.35(%)
  • Britannia Inds.
    4,946.05 4,946.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Caplin Point Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4464.0
  • ISIN : INE475E01026
2,754.90 -41 (-1.45%)
  • As on 14 Sep 2026 (EOD)

  • Today’s Low

    2,716.00

  • Today’s High

    2,790.10

  • Open

    2,790.10

  • Perv Close

    2,795.40

  • 52W Low

    1,500.30

  • 52W High

    2,877.30

Key Indicators

  • P/E(TTM)

    49.89

  • Mar.Cap (₹Cr.)

    20,940.46

  • Div & Yield %

    0.29

  • Book Value(₹)

    269.76

  • Debt-Equity Ratio

    -1.45

  • AGM Date

    11-Sep-2026

  • EPS

    55.22

  • P/E Ratio

    49.89

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    20,940.46

  • RONW (%)

    24.52

  • ROCE (%)

    26.67

Score Board

  • Equity (₹ in Cr.)

    15.20

  • BV (₹)

    269.80

  • Sales( ₹ in Cr.)

    738.33

  • NP (in Cr.)

    383.29

  • NP Var(%)

    13.0

  • Div%

    400.0

  • CPS (₹)

    53.80

  • EPS (₹)

    50.40

  • Traded Value (₹ in Lakhs)

    20,939.32

  • 52 Week High

    2,877.30

  • 52 Week Low

    1,500.30

  • Price BSE

    2755.0

  • Price NSE

    2,755.00

  • Market Capital( in Cr.)

    20,939.32

  • P/C Ratio

    51.20

  • P/E Ratio

    54.60

  • Price Vs.BV

    50.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 738.33 752.41 625.09 528.61 528.06 482.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 738.33 752.41 625.09 528.61 528.06 482.68
Other Income 195.37 134.59 105.84 99.00 56.55 18.62
Stock Adjustments 12.37 -24.36 43.68 1.67 9.00 0.57
Total Income 946.07 862.64 774.61 629.28 593.61 501.87
EXPENDITURE :            
Raw Materials 241.33 213.81 248.90 199.73 213.65 195.40
Power and Fuel Cost 13.64 14.11 15.43 9.89 9.54 6.36
Employee Cost 47.72 52.13 38.11 36.68 30.47 26.59
Other Manufacturing Expenses 27.05 24.00 25.43 13.73 10.81 7.75
Selling and Administration Expenses 65.81 75.50 40.75 40.30 43.51 28.12
Miscellaneous Expenses 17.37 16.53 13.07 10.03 9.46 5.10
Employee Benefit Expenses 47.72 52.13 38.11 36.68 30.47 26.59
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 412.92 396.08 381.69 310.36 317.44 269.32
Operating Profit 533.15 466.56 392.92 318.92 276.17 232.55
Interest 0.20 0.12 0.10 0.12 0.09 0.17
Gross Profit 532.95 466.44 392.82 318.80 276.08 232.38
Depreciation 25.43 24.77 27.08 25.65 25.77 22.44
Profit Before Tax 507.52 441.67 365.74 293.15 250.31 209.94
Current Tax 109.49 102.90 86.12 66.58 61.62 54.88
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.45 -0.72 -4.09 -7.69 0.82 -1.17
Reported Net Profit 396.58 339.49 283.71 234.26 187.87 156.23
Extraordinary Items 13.29 -0.33 1.19 1.17 0.75 4.67
Adjusted Net Profit 383.29 339.82 282.52 233.09 187.12 151.56
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,634.99 1,333.49 1,083.95 880.01 714.84 561.64
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 45.61 37.99 34.17 30.32 22.70 3.03
P & L Balance carried down 1,985.96 1,634.99 1,333.49 1,083.95 880.01 714.84
Dividend 22.81 18.99 15.19 15.16 11.35 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 400.00 300.00 250.00 225.00 200.00 150.00
Dividend Per Share(Rs) 8.00 6.00 5.00 4.50 4.00 3.00
Earnings Per Share-Unit Curr 52.18 44.67 37.35 30.86 24.78 20.65
Earnings Per Share(Adj)-Unit Curr 52.18 44.67 37.35 30.86 24.78 20.65
Book Value 269.80 223.81 183.03 150.19 122.78 100.29
Book Value(Adj)-Unit Curr 269.80 223.81 183.03 150.19 122.78 100.29

Shareholding Pattern

  • Promoter Group

    70.57%

  • Public Share Holding

    29.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,637,000 3.47 2,637,000 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 51,005,353 67.10 51,005,353 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 53,642,353 70.57 53,642,353 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1 0.00 1 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,550 0.00 3,550 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,373,994 5.75 4,373,994 147
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 22,204 0.03 22,204 2
Mutual Funds / UTI 1,540,686 2.03 1,540,686 19
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 329,117 0.43 329,117 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 6,269,552 8.25 6,269,552 185
2] Non Institution
Bodies Corporate 1,187,868 1.56 1,187,368 612
Clearing Members 0 0.00 0 0
Directors of their Relatives 7,000 0.01 7,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,047,402 1.38 1,042,402 3,192
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 323,652 0.43 323,652 1,330
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,883,490 2.48 1,883,490 32
Individuals holding nominal share capital up to Rs. 1 lakh 9,231,283 12.14 8,695,658 89,013
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 8,846 0.01 8,846 7
Others 2,348,235 3.09 2,298,235 5
Sub Total 16,099,791 21.18 15,508,666 94,193
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 76,011,696 100.00 75,420,571 94,385

Company Background

Caplin Point Laboratories LtdPharmaceuticals - Indian - Formulations

  • Caplin Point Laboratories Ltd
  • BSE Code : 4464.0
  • ISIN : INE475E01026

  • Incorporation Year

    1990

  • Registered Office

    Ashvich Towers 3rd Floor
    No 3 Developed Plots Ind Estat, Chennai,
    Tamil Nadu-600096

  • Telephone

    91-44-24968000/71148000/28156653

  • FAX

    91-44-28154952

  • Chairman

    C C Paarthipan

  • Managing Director

  • Company Secretary

  • Auditor

    Brahmayya & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Registry Mgt Ser.Pv
    2nd Floor Kences Tow,
    1 Ramakrishna Street,Usman Road T.Nagar
    Mumbai - Chennai-600017

Caplin Point Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Caplin Point Lab 2,754.75 933.70 738.33 49.89 26.98
Abbott India 25,586.10 7,217.19 6,929.05 33.67 43.78
Astrazeneca Phar 6,785.35 2,304.07 2,275.58 100.01 27.86
Glaxosmi. Pharma 2,837.20 3,932.76 3,790.20 45.32 58.17
Novartis India 2,393.15 393.10 354.33 60.43 15.94
Cipla 1,365.00 20,102.60 18,979.95 35.87 13.88
Bliss GVS Pharma 722.45 773.53 729.81 67.14 12.51
Amrutanjan Healt 490.35 520.13 502.55 26.26 24.16
Fermenta Biotec. 475.05 474.15 450.25 22.18 18.77
Guj. Themis Bio. 423.35 168.25 165.82 113.20 18.05
Ambalal Sarabhai 40.61 19.52 3.94 75.20 6.77